CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients

Title
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 19, Issue 19, Pages 5300-5309
Publisher
American Association for Cancer Research (AACR)
Online
2013-10-02
DOI
10.1158/1078-0432.ccr-13-0143

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now